Oric Pharmaceuticals, Inc.盘中异动股价大跌6.28%报5.30美元

市场透视2025-04-30

北京时间2025年04月30日21时33分，Oric Pharmaceuticals, Inc.（ORIC.us）股票出现异动，股价急速下挫6.28%。截至发稿，该股报5.30美元/股，成交量1.8187万股，换手率0.03%，振幅3.27%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.28亿美元，每股收益-1.83美元，毛利-1.11百万美元，市盈率-2.96倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2531055001?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-30 21:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2531055001","market":"us","top_or_hot":-1,"title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌6.28%报5.30美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月30日21时33分，Oric Pharmaceuticals, Inc.（ORIC.us）股票出现异动，股价急速下挫6.28%。截至发稿，该股报5.30美元/股，成交量1.8187万股，换手率0.03%，振幅3.27%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.28亿美元，每股收益-1.83美元，毛利-1.11百万美元，市盈率-2.96倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213335aa2c7f4b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oric Pharmaceuticals, Inc.盘中异动 股价大跌6.28%报5.30美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOric Pharmaceuticals, Inc.盘中异动 股价大跌6.28%报5.30美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-30 21:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213335aa2c7f4b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月30日21时33分，Oric Pharmaceuticals, Inc.（ORIC.us）股票出现异动，股价急速下挫6.28%。截至发稿，该股报5.30美元/股，成交量1.8187万股，换手率0.03%，振幅3.27%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.28亿美元，每股收益-1.83美元，毛利-1.11百万美元，市盈率-2.96倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213335aa2c7f4b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORIC","symbol_name":"Oric Pharmaceuticals Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213335aa2c7f4b&s=b","article_id":"2531055001","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213335aa2c7f4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2531055001","pubTimestamp":1746020015,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月30日21时33分，Oric Pharmaceuticals, Inc.股票出现异动，股价急速下挫6.28%。截至发稿，该股报5.30美元/股，成交量1.8187万股，换手率0.03%，振幅3.27%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Regulus Therapeutics Inc.、Nutriband Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为127.28%、14.53%、10.88%，振幅较大的相关个股有Nutriband Inc.、Polypid Ltd.、Aligos Therapeutics, Inc.，振幅分别为15.67%、14.43%、12.57%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ORIC":"Oric Pharmaceuticals Inc."},"translate_title":"Oric Pharmaceuticals, Inc. shares fell 6.28% to $5.30 after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORIC":0.9},"content_text":"北京时间2025年04月30日21时33分，Oric Pharmaceuticals, Inc.（ORIC.us）股票出现异动，股价急速下挫6.28%。截至发稿，该股报5.30美元/股，成交量1.8187万股，换手率0.03%，振幅3.27%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.28亿美元，每股收益-1.83美元，毛利-1.11百万美元，市盈率-2.96倍。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Regulus Therapeutics Inc.、Nutriband Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Silo Pharma, Inc.较为活跃，换手率分别为127.28%、14.53%、10.88%，振幅较大的相关个股有Nutriband Inc.、Polypid Ltd.、Aligos Therapeutics, Inc.，振幅分别为15.67%、14.43%、12.57%。Oric Pharmaceuticals, Inc.公司简介：ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。它拥有一系列旨在通过利用其在三个特定领域的专业知识来对抗癌症中的耐药机制的治疗方案：激素依赖性癌症、精准肿瘤学和关键肿瘤依赖性。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。公司有一个运营部门，专注于发现和开发旨在对抗癌症耐药机制的治疗方案。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2531055001","isCrawlerRequest":true}

Oric Pharmaceuticals, Inc.盘中异动 股价大跌6.28%报5.30美元

精彩评论

Oric Pharmaceuticals, Inc.盘中异动股价大跌6.28%报5.30美元